2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Cancer Cachexia: new trials by email Literature Review of Cancer Cachexia trials Research Report on Cancer Cachexia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Ruxolitinib in the Treatment of Cachexia in Patients With Tumor-Associated Chronic Wasting Diseases. Ruxolitinib - Cancer Cachexia | Phase 2 | Terminated | Kantonsspital Aarau | 8 | 2014-04-20 | 2019-02-28 |
| The Role of Ghrelin in Cancer Cachexia Anamorelin HCl, Placebo - Cancer Cachexia | Phase 2 | Terminated | VA Office of Research and Development | 10 | 2012-06-01 | 2018-07-17 |
Cachexia (1)
Body Weight (1) · Body Weight Changes (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Thinness (1) · Weight Loss (1)
ruxolitinib (1)
Kantonsspital Aarau (1) · VA Office of Research and Development (1)
Switzerland (1) · United States (1)
Jose M. Garcia, MD PhD (1) · Mario Bargetzi, MD (1) · Nathan Cantoni, MD (1)